I agree with all that you have mentioned, I aways give the...

I agree with all that you have mentioned, I aways give the company the benefit of the doubt but more recently faux pas after faux pas. Ian Buchhorn's resignation from the board does not help matters as far as I am concerned.
Ian it seems will never criticises the board and seems to have offered plenty of help to Jeneta Owens when taking up her new role as M.D.

I hope from hereon we see Godolphin keep to its timelines, we shareholders want to see positive news announcements What we have witnessed are some announcements that do not keep shareholders accurately in the picture and then changes are made without reference.

For several years I had been trying to encourage GRL's chair to take up a holding in GRL. I was given a couple of reasons why he held firm against investing.

It surprised me somewhat to note during the recent cap raising, two board members bought shares on market at a cheaper rate than had they supported the company.
Perhaps there was legitimate were reasons, it wasn't a good look.